Rank: 69 (Previous rank: N.A.)
CEO: Jan Keltjens
Headquarters: Queensbury, NY
Industry: Health Care
Revenue: $180.3 million
(four quarters to 12/31/08)
Return to investors: -18.76%
(three years to 12/81/08, annualized rate)
Angiodynamics develops medical devices that enable minimally invasive treatment of cancer and peripheral vascular disease. Early this year, the company added to its product line an infusion catheter that delivers drugs through the renal arteries directly to the kidneys. Its new NanoKnife technology also holds promise for the focal treatment of cancer tumors.
... What Readers Say
They speak out on the fastest-growing small public companies ...
|Executive||2008 Total Compensation